Our Fund II press release for raising $35M to double down on the thesis that women-led companies outperform.
FinSMEs reports of $35M True Wealth Ventures Fund II close.
SAN DIEGO, June 21, 2022 /PRNewswire/ -- DERMALA Inc., a science-based consumer dermatology company developing novel, microbiome-based solutions for chronic skin conditions, announced today the issuance of the U.S. Patent No. 11,364,214 - COMPOSITIONS AND METHODS FOR TREATING ECZEMA. This patent is the 4th patent in the expanding DERMALA intellectual property portfolio. It covers using [...]
DERMALA launches Skin Tests to measure the oil level and pH of the skin to better personalize their monthly acne treatment
TWV’s portco Dermala extends its product range to include a 2nd microbiome-powered line of products for eczema
Consumer dermatology company, Dermala, launches post-acne microbiome balancing maintenance line
TWV’s portco Jiminy's recognized as the "Best Sustainable Dog Food" on Forbes list
Journal of Medical research on the diagnostic accuracy of BrainCheck’s digital cognitive testing for dementia
Check out our April newsletter with an update on our 3rd Fund II investment, Fund I performance and another impact investor accolade
TWV’s portfolio co. Queen of Raw has created an impact footprint reporting tool on Raw Chain with Solve-MIT
